Member Info for Dr_Horrible

The owning company seems to be called Antioxidair B.V.

I think it consists of 1 person.

Yep, the FlyFit stuff looks really good now. Much superior packaging and website information than it had previously. If only they could sort out cheap international postage and tell us who they are. There is no About Us or Contact Us with any decent information on them. Before I purchase from a website, I want to know who they are. Also they don't seem to be known on TrustPilot. They have a great product, but don't appear to want to sell it.

"Scientists have also found a natural substance against cardiovascular and cerebrovascular diseases - water-soluble tomato concentrate in the common vegetable "tomato". Reduce the occurrence of diseases such as atherosclerosis."

The science is moving along nicely. Previously we have been talking about anti-thrombotic properties of FF and blood pressure reduction, but now we are talking about also reducing atherosclerosis, the build up of fatty deposits on the arterial wall.

So that evidence building up that FF is beneficial to blood cholesterol, blood flow and blood pressure, the holy trinity of heart health.

Hopefully it is all leading to where we hope it will, that FF is recommended globally as a primary prevention against cardiovascular disease.

I am assuming the whole pricing for FF changes in January next year with the ramp up in production.

Moon used to say that the margin on FF was good , but becomes excellent/high when the volumes go up.

https://m.momoshop.com.tw/goods.momo?i_code=9854910

Why would you sell on the cusp of the first proper major deal that Provexis have seen? I am expecting this next 12 months to be transformational for PXS and FF, having waited for a 1/4 of my life. One day I may even get my money back!!! :)

Gets a mention in the known product.

https://www.luxuriousmagazine.com/clinique-la-prairie-clp-holistic-complex/

I don't recall seeing this one previously.

WS,
Certainly hoping for something this year, but....

My expectations are
SAMR submission - end of June
SAMR approval - end of September
Start of By-Health Contract - January
Fist Major Product Launch - March/April.

Let's see just how wrong I am :)

Also hoping that they have a number of other Chinese business customers lined up on the distribution side of things.

What are other people's expectations for milestone dates?

We all know that the timeline is broadly this year for SAMR approvals, next year for major product launches. This transformation will put PXS on the radar. I am just hoping that the current Covid lockdowns in China are not impacting that timeline. They are bat**** crazy with their zero Covid policy.

This share is long forgotten and off any radar. That’s why it has a crazy large spread. We all hope that changes when they move into profit off the back of BH orders and then the radar picks it up again.

I read the Chinese article earlier when it came up, quite interesting.

My favourite part of that page is:

FlyFit Travel is being served on Emirates Airlines and American Airlines First Class globally.

Naz,

From the Sept RNS:

By-Health currently expects to be in a position to complete the last of its eight studies and file its regulatory submission to the SAMR for Fruitflow in the first half of 2022.

This was then dropped in the subsequent RNS, so we don't know if it is still valid.

The link doesn't work for me, I just get 'The specified blob does not exist'.

I seems like the product is pretty much there. Not sure whether they are waiting on other patent approvals prior to launch.
Would be good to know what DSMs plans are with the samples.

Wellsite,

Yes, I won't hold my breath waiting for that news.

The last we heard on it was:

Sept 21
The Company continues to work on a potential Fruitflow+ nitrates product which would be supported by the Company's strong patent position in this area. The product would have anti-inflammatory and circulation benefits for athletes seeking to recover after exercise, properties which would also be potentially beneficial to a wide range of other consumers to include people who are less active and people who suffering from the symptoms of basic ageing. In collaboration with DSM a trial batch of Fruitflow+ nitrates development products was manufactured during the year and sold to DSM.

Dec 21
Patents have been granted around Europe and in the US, Australia, Brazil, China, Hong Kong, Israel, Japan, South Korea, the Philippines, New Zealand and Mexico. Further patent protection is being sought in six territories, with potential patent protection out to December 2033.

All we can do is just wait for news on By-Health's SAMR submission/approval and DSM contract negotiations. Expect both bits of news by the end of the year.

Will also be interesting to find out what is going on with the FF as a drug, FF+ sales in China, new FF+ direct selling customers, FF+ Nitrates, FF manufacturer scale-up of production.

The section of the study called ‘ Fruitflow and aspirin synergistically inhibited ADP- and collagen-induced platelet aggregation’ shows amazing results.

We’ll worth a read if you haven’t read it already.

Funded by By-Health.